Stockreport

USPTO Grants Composition of Matter Patent to Achillion for ACH-4471, First-in-Class Small Molecule Complement Alternative Pathway Factor D Inhibitor

ACHISON INC A  (ACHN) 
Last achison inc a earnings: 11/7 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.achillion.com/investor-relations
PDF NEW HAVEN, Conn., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that the U.S. Patent and Trademark Office (USPTO) has [Read more]